Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Ferrari

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Current Drug Safety|August 12, 2008
Headache: one of the most common and troublesome adverse reactions to drugsAnna Ferrari
Cephalalgia : an International Journal of Headache|June 1, 2010
LDQ--validated for headache diseases?Gunther Haag, Anna Ferrari
Clinical Therapeutics|February 20, 2021
Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative ReviewAnna Ferrari, Cecilia Rustichelli
Cephalalgia : an International Journal of Headache|July 22, 2010
Pharmacoepidemiology of triptans in a headache centreAnna Ferrari, Luca Spaccapelo, Emilio Sternieri
Expert Opinion on Pharmacotherapy|March 23, 2022
Atogepant: an emerging treatment for migraineCecilia Rustichelli, Rossella Avallone, Anna Ferrari
Diagnosis (Berlin, Germany)|November 23, 2018
Willingness-to-pay threshold for preventing spurious hemolysis during blood sample collectionGiuseppe Lippi, Chiara Bovo, Anna Ferrari
Headache|August 9, 2008
Past, present, and future prospects of medication-overuse headache classificationAnna Ferrari, Ciro Coccia, Emilio Sternieri
Expert Opinion on Investigational Drugs|October 21, 2017
Glutamate receptor antagonists with the potential for migraine treatmentAnna Ferrari, Cecilia Rustichelli, Carlo Baraldi
European Journal of Public Health|January 28, 2021
Is COVID-19 lockdown associated with vitamin D deficiency?Giuseppe Lippi, Anna Ferrari, Giovanni Targher
Expert Opinion on Drug Metabolism & Toxicology|June 2, 2015
Medication overuse and chronic migraine: a critical review according to clinical pharmacologyAnna Ferrari, Carlo Baraldi, Emilio Sternieri
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Current Drug Safety|August 12, 2008
Headache: one of the most common and troublesome adverse reactions to drugsAnna Ferrari
Cephalalgia : an International Journal of Headache|June 1, 2010
LDQ--validated for headache diseases?Gunther Haag, Anna Ferrari
Clinical Therapeutics|February 20, 2021
Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative ReviewAnna Ferrari, Cecilia Rustichelli
Cephalalgia : an International Journal of Headache|July 22, 2010
Pharmacoepidemiology of triptans in a headache centreAnna Ferrari, Luca Spaccapelo, Emilio Sternieri
Expert Opinion on Pharmacotherapy|March 23, 2022
Atogepant: an emerging treatment for migraineCecilia Rustichelli, Rossella Avallone, Anna Ferrari
Diagnosis (Berlin, Germany)|November 23, 2018
Willingness-to-pay threshold for preventing spurious hemolysis during blood sample collectionGiuseppe Lippi, Chiara Bovo, Anna Ferrari
Headache|August 9, 2008
Past, present, and future prospects of medication-overuse headache classificationAnna Ferrari, Ciro Coccia, Emilio Sternieri
Expert Opinion on Investigational Drugs|October 21, 2017
Glutamate receptor antagonists with the potential for migraine treatmentAnna Ferrari, Cecilia Rustichelli, Carlo Baraldi
European Journal of Public Health|January 28, 2021
Is COVID-19 lockdown associated with vitamin D deficiency?Giuseppe Lippi, Anna Ferrari, Giovanni Targher
Expert Opinion on Drug Metabolism & Toxicology|June 2, 2015
Medication overuse and chronic migraine: a critical review according to clinical pharmacologyAnna Ferrari, Carlo Baraldi, Emilio Sternieri
Pageof 16